SCHEMBL4156436

SCHEMBL4156436

COc1ccc2c(N(F)c3cccc(Cl)c3)nc(OCCCN3CCOCC3)nc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ SRC P12931 3/20 0.42
▸ FLT3 P36888 1/20 0.42
▸ KDR P35968 3/20 0.41
▸ AVPR1B P47901 5/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ EGFR P00533 4/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ FLT1 P17948 1/20 0.39
▸ FLT4 P35916 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4156430 0.75 EGFR (0.61) SRCKDREGFRFGFR1FLT1
SCHEMBL5040071 0.74 EGFR (0.61) SRCFLT3KDREGFRFLT1
SCHEMBL15732881 0.67 KMT2A (0.82) TSHRNPSR1FLT3MEN1KMT2A
SCHEMBL5423360 0.66 EGFR (0.66) SRCFLT3KDREGFRFLT1
SCHEMBL16245396 0.66 HRH3 (0.54) ALDH1A1TSHRSMN1; SMN2NPSR1SRC
SCHEMBL3351728 0.65 ALDH1A1 (0.51) ALDH1A1TSHRSMN1; SMN2NPSR1SRC
SCHEMBL31061228 0.65 ALDH1A1 (0.51) ALDH1A1TSHRSMN1; SMN2NPSR1SRC
SCHEMBL30017995 0.65 MAP2K1 (0.52) ALDH1A1SRCKDREGFRKDM4E
SCHEMBL23804879 0.64 HRH3 (0.79) ALDH1A1TSHRSMN1; SMN2NPSR1CYP2D6
SCHEMBL2502393 0.64 ALDH1A1 (0.54) ALDH1A1TSHRSMN1; SMN2NPSR1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8080573-B2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-12-20 — — US disclosed
US-20090156619-A1 Heterocycle Substituted Amide and Sulfur Amide Derivatives as Histone Deacetylase (HDAC) Inhibitors MSD ITALIA S.R.L. (IT) 2009-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156619-A1 Heterocycle Substituted Amide and Sulfur Amide Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC1, HDAC6, HDAC11 ALDH1A1 500/4885TSHR 758/4885SMN1; SMN2 404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback